Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks hemophilia a risks in mothers and babies

NCT ID NCT07414511

Recruiting now Knowledge-focused Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 500 mother-child pairs where the mother has a severe hemophilia A gene. It aims to understand bleeding risks during pregnancy and childbirth for mothers, and how children develop antibodies to factor VIII treatment. By observing families over time, researchers hope to identify genetic and environmental factors that influence these outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could improve understanding of bleeding risks during pregnancy for mothers with hemophilia A and how children develop antibodies to treatment.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly lead to new therapies. Results may take years and may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemophilia A Hemorrhage hemorrhagic disease Postpartum Hemorrhage pregnancy disorder severe hemophilia A thrombotic disease vascular hemostatic disease X-linked disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLOIMMUNIZATION BLEEDING DISORDER CARRIER OF HEMOPHILIA A FACTOR VIII (FVIII) FVIII DEFICIENCY HEMOPHILIA A HEMOPHILIA A, SEVERE HEMORRHAGE, POSTPARTUM INHIBITORS MATERNAL BLOOD LOSS PREGNANCY PREGNANCY COMPLICATIONS X-LINKED

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Washington

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••